277 related articles for article (PubMed ID: 7773544)
1. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.
Polasek TM; Elliot DJ; Somogyi AA; Gillam EM; Lewis BC; Miners JO
Br J Clin Pharmacol; 2006 May; 61(5):570-84. PubMed ID: 16669850
[TBL] [Abstract][Full Text] [Related]
3. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
4. Repeated idazoxan increases brain imidazoline receptors in normotensive (WKY) but not in hypertensive (SHR) rats.
Olmos G; Miralles A; Barturen F; García-Sevilla JA
J Neurochem; 1991 Nov; 57(5):1811-3. PubMed ID: 1681037
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
6. The role of imidazoline receptors in blood pressure regulation.
Hamilton CA
Pharmacol Ther; 1992; 54(3):231-48. PubMed ID: 1361236
[TBL] [Abstract][Full Text] [Related]
7. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
[TBL] [Abstract][Full Text] [Related]
8. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
Feldman JM; Chapman B
Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
[TBL] [Abstract][Full Text] [Related]
10. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.
Chiuccariello L; Cooke RG; Miler L; Levitan RD; Baker GB; Kish SJ; Kolla NJ; Rusjan PM; Houle S; Wilson AA; Meyer JH
Int J Neuropsychopharmacol; 2015 Aug; 19(1):. PubMed ID: 26316187
[TBL] [Abstract][Full Text] [Related]
11. Evidence that drug binding to non-adrenergic [3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor.
Wikberg JE; Uhlén S; Chhajlani V
Pharmacol Toxicol; 1992 Mar; 70(3):208-19. PubMed ID: 1349748
[TBL] [Abstract][Full Text] [Related]
12. Further pharmacological characterization of [3H]idazoxan binding sites in rat brain: evidence for predominant labeling of alpha 2-adrenergic receptors.
Raymon HK; Smith TD; Leslie FM
Brain Res; 1992 Jun; 582(2):261-7. PubMed ID: 1356583
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
14. Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptors.
Sjöholm B; Lähdesmäki J; Pyykkö K; Hillilä M; Scheinin M
Br J Pharmacol; 1999 Nov; 128(6):1215-22. PubMed ID: 10578134
[TBL] [Abstract][Full Text] [Related]
15. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
[TBL] [Abstract][Full Text] [Related]
17. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.
Brady LS; Gold PW; Herkenham M; Lynn AB; Whitfield HJ
Brain Res; 1992 Feb; 572(1-2):117-25. PubMed ID: 1351783
[TBL] [Abstract][Full Text] [Related]
18. Cumulative effects of irreversible MAO inhibitors in vivo.
Felner AE; Waldmeier PC
Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
[No Abstract] [Full Text] [Related]
19. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
Saura J; Kettler R; Da Prada M; Richards JG
J Neurosci; 1992 May; 12(5):1977-99. PubMed ID: 1578281
[TBL] [Abstract][Full Text] [Related]
20. Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig.
Wikberg JE; Uhlén S; Chhajlani V
Eur J Pharmacol; 1991 Feb; 193(3):335-40. PubMed ID: 1675995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
